As reported (b)(4) 2014, a (b)(6) old male patient presented for a nanoknife ablation for two lesions of the liver.The first ablation was successfully completed with no reports of complications or device malfunctions.During the second ablation, the patient experienced atrial fibrillation.The procedure was aborted and a cardiologist was consulted.The cardiologist used a defibrillator to regulate the patient's heartbeat.It was determined the patient's second lesion would be treated using a combination of rfa and stereoactive ablation radiation therapy.There was no report of permanent harm or injury to the patient due to the event.It was reported the nanoknife system is available for return for evaluation to the manufacturer.
|
It was reported that the device involved in the incident is available to be returned to the manufacturer for evaluation.To date, the device has yet to be returned.Attempts are being made to obtain the device.An investigation into the root cause for event is currently in progress.A review of the device history records was performed for the serial number (b)(4).The review confirms that the unit met all material, assembly, and performance specifications.The results of the unit evaluation will be sent via a f/u medwatch.
|